We have investigated the association of multiple sclerosis (MS) with polymorphisms in the IL4R gene in 332 single-case MS families. IL4R encodes a subunit of the interleukin-4 receptor, a molecule important for T-cell development and differentiation, and is a gene shown to be associated with immune-related diseases such as asthma and type I diabetes. By genotyping two promoter and eight coding IL4R SNPs and identifying haplotypes (complex alleles) in the MS families, stratified for HLA genotype, we have observed evidence of the association of the IL4R gene to MS. In particular, we have identified a specific susceptibility haplotype, and observe that the risk is conferred primarily to individuals not carrying the high MS-risk HLA DR2 (DRB1*1501-DQB1*0602) haplotype (nominal P ¼ 0.009). These findings suggest a potentially important role for the IL4R gene in predisposition to MS, and provide further evidence of its relevance as a candidate gene for immune-related diseases.
Introduction
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system white matter, characterized by inflammation, demyelination and axonal injury. 1 In populations of Northern European descent it is the most common cause of acquired neurological dysfunction arising during early-and mid-adulthood, affecting more than one million people in North America and Western Europe. The course of the disease may consist of recurrent attacks each followed by a variable degree of recovery (relapsing remitting, RR) or, in a minority of patients, of a progressive course from onset (primary progressive, PP). 2 Intermediate phenotypes are also common. A large body of research supports a multifactorial etiology, with an underlying genetic susceptibility likely acting in concert with undefined environmental exposures, resulting in an autoimmune response against myelin proteins and progressive neurological dysfunction. 3, 4 There is substantial evidence that many genetic loci, as well as environmental factors, are involved in predisposition to MS. 3 The genetic locus with the largest contribution to familial clustering is the HLA region on chromosome 6p21.3 (MS1). The HLA-DR2 haplotype (viz, HLA-DRB1*1501-DQA1*0102-DQB1*0602) has been consistently associated with MS in Northern European populations. 3 However, in families who do not carry DR2, linkage to chromosome 6p21 is often not seen; this is generally thought to be consistent with the presence of locus heterogeneity in MS, 5-7 although this conclusion is not without question. 8 It is these presumed many other loci of smaller effect, but which account for the large portion of the total genetic risk for MS, that we and others seek to identify.
Interindividual differences in immune response, and in the activation, regulation and recruitment of T cells, in particular, may help explain the variation in the predisposition to and course of MS. Association studies with candidate genes involved in immune responses, such as those encoding elements of T-cell activation pathways, represent one approach to finding MS susceptibility and diseasemodifying loci. 9 The IL4R gene is one such candidate, as it encodes a subunit of the interleukin-4 (IL-4) receptor heterodimer, a molecule critical to T helper cell differentiation and commitment. 10 Both the IL-4 receptor and its ligand IL-4 have been shown to be localized to immune cells at the site of active MS lesions in the brain, suggesting a role for these molecules in disease progression. 11 Changes to IL4R amino-acid residues, particularly the Ile50Val, Ser478Pro and Gln551Arg polymorphisms, are proposed to be functionally important and impact IL-4 receptor signaling (see Shirakawa et al 12 and citations therein). IL4R SNPs have been associated with susceptibility to immune-related diseases including asthma and atopy, [12] [13] [14] and, by constructing multi-SNP IL4R haplotypes, associations to type I diabetes (T1D) have been demonstrated. 15, 16 The IL4R gene, at 16p11-p12, has been identified as a candidate gene for MS by linkage 5, 17 and by the association of individual IL4R SNPs. 18 We wished to reproduce and extend those findings by using a familybased cohort in which we could directly observe the transmission of multi-SNP IL4R haplotypes and detect their association with MS, if any. Since the HLA-DR2 haplotype confers such a large genetic risk for MS, such that its presence may obscure other, smaller genetic signals, our approach was to also look into families without the high-risk HLA haplotype. This approach had previously enabled the detection of a T1D-protective IL4R haplotype in a US family-based cohort following stratification for the high T1D-risk HLA-DR3/4 genotype. 16 Therefore, in the analyses of the IL4R data that we present here, we stratify the families based on whether the affected individual is HLA-DR2 positive or negative.
Results and discussion
We genotyped the members of 332 single-case MS families at 10 SNPs in the IL4R gene ( Table 1 ). The transmission-disequilibrium test (TDT; 19 ) was performed on the IL4R genotype data to test for the association of the individual alleles of the 10 IL4R SNPs to MS. The 332 nuclear families used in this study consisted of unaffected parents and a single ascertained affected individual. 20 There were also 84 unaffected siblings present in 71 families, for a total of 1080 genotyped individuals. The 332 unrelated patients had a definite MS diagnosis and a RR or secondary-progressive (SP) disease course. 2 Among the patients, the female/male ratio ¼ 2.9:1, mean age of onset ¼ 27.177.9 years and mean disease duration ¼ 8.877.1 years. IRB approval and informed consent were obtained from all study participants.
The results of the single SNP TDT are shown in Table 1 , for all families together and for the DR2-positive andnegative groups separately. Since we look for associations using all families together and for the two family subgroups, we apply a Bonferroni adjustment of three times the nominal P-values to take account of these multiple comparisons. As the SNPs are in linkage disequilibrium and so are not independent, we apply no further adjustment here. We observed no significant associations of individual SNPs to MS in our full cohort, as well as when families are stratified for HLA-DR2 (Table 1) . This remains true even without Bonferroni adjustment of P-values for the HLA stratification.
The association of 10 SNP IL4R haplotypes with MS was assessed using TRANSMIT, which facilitates the estimation and observation of haplotypes transmitted from parents to affected offspring. 24 This multi-SNP TDT analysis ( Table 2 ) revealed evidence of overtransmission of a single 10 locus IL4R haplotype (labeled '1.2.1.1.1.1.1.1.1.1' or CC(H-1); Table 2 ) in the DR2-negative group (nominal P ¼ 0.009). We note that after applying a Bonferroni correction of 10 for stratification into 10 haplotypes, the adjusted P ¼ 0.087. The CC(H-1) haplotype confers an odds ratio of 1.4 (comparing this haplotype with all others) in DR2-negative families. Among all families, the transmission of this single haplotype also tends toward overtransmission, but does not reach statistical significance (nominal P ¼ 0.052).
A recent report by Hackstein et al 18 investigated the association of IL4R SNPs and MS using a case-control cohort of German MS patients. In that study, the associations of six individual SNPs (viz, SNPs 3, 5, 7, 8 21 using unlabeled primers and SyBr Green fluorescence detection in a Prism s 7900HT instrument (Applied Biosystems; Foster City, CA, USA). SNPs 3-10 were genotyped using an immobilized-probe linear array hybridization methodology described previously. 16 The remaining columns list the observed transmissions of the reference allele at each of the 10 IL4R SNP loci individually. The number of informative transmissions for each SNP and the percent transmission are listed. The TDT analysis was performed on the complete MS cohort, and after stratification for HLA-DR2 status, as described below, using GeneHunter (version 2.1.r2). 22, 23 Individuals were previously genotyped at HLA loci, and carry the high-risk HLA-DR2 if they possess the DRB1*1501-DQB1*0602 haplotype. 20 Families were stratified into two groups based on the HLA genotype of the affected individual: 158 families are 'DR2-positive' group and 174 are 'DR2-negative' by this criterion. and 9 (Table 1) plus the 'S411L' SNP) to RR and SP MS vs PP MS was assessed. The authors found a significant association of IL4R Q551R genotypes in PP MS subjects when compared to controls, but none among RR and SP MS subjects, 18 and suggest that the SNP may play a role in predisposition to PP MS. It is difficult to compare that study and ours, as they differ in several ways, including case-control vs family sampling schemes, and our a priori stratification based on HLA DR2 genotype. However, in this report we are able to demonstrate an association of IL4R variants with RR and SP MS by stratifying families by DR2 status, but more importantly by observing the transmission of 10 SNP haplotypes. Taken together, the latter and current reports provide accumulating evidence for a potential role for IL4R in MS susceptibility.
The association of haplotype CC(H-1) with MS that we observe may reflect the combined effect of the 10 SNPs that compose the haplotype. Haplotype CC(H-1) differs from the haplotype CT(H-1) by a single allele at SNP T(À1914)C, yet the transmission of the latter haplotype does not significantly depart from expectation (Table 1) . In addition, the T(À1914)C promoter SNP does not individually display significant transmission distortion (SNP #2 in Table 1 ), suggesting that the alleles at this SNP must be present in the context of a haplotype to confer susceptibility. The potential regulatory role of the T(À1914)C SNP has not been as well characterized as that of the C(À3223)T SNP, which has been demonstrated to affect the level of soluble IL4R (sIL4R) protein in blood. 25 As these two promoter SNPs are in strong linkage disequilibrium, a role for the T(À1914)C SNP in sIL4R expression as well cannot be discounted, but alternatively its variation may be linked to other regulatory consequences. We speculate that it is the expression of an IL4R protein possessing only wild-type amino acids at polymorphic positions (haplotype H-1), expressed by one specific allelic arrangement of cisacting sequences, that confers the increased risk of MS. In vitro studies will be needed to investigate the tissue-and signal-specific expression patterns of the CC(H-1) haplotype, in comparison to the CT(H-1) and other haplotypes. It is also formally possible, alternatively, that the 10 IL4R SNPs studied here do not capture all the variation defining the MS-susceptible haplotype, and other SNPs on or in LD with haplotype CC(H-1) may be involved.
The observations reported here will require further replication in other MS cohorts to confirm the association of one or more IL4R haplotypes as risk factors for MS predisposition. Although the current evidence indicates that the IL4R effect is not very strong, this gene might represent a potential therapeutic target, and thus there is value in confirming its role in MS and other autoimmune disorders. Association of IL4R haplotypes with MS was assessed using TRANSMIT (version 2.5.4). 24 The haplotype frequencies shown in column three represent EM estimates among the parents and among all the families as calculated by TRANSMIT. Observed and expected haplotype transmission counts for all families and for HLA-DR2-stratified groups are presented in the remaining columns. The table shows only the 10 most frequent haplotypes, those that were observed in at least four transmission events in any group. Genotypes of unaffected siblings were used by TRANSMIT to determine haplotypes when they were available, but only the affected individual was used for the calculation of association. Each haplotype is listed by the ordered set of alleles present at each of the 10 IL4R SNPs listed in Table 1 . A '1' denotes the presence of the reference allele, a '2' the presence of the variant allele for each SNP, as described in Table 1 . Haplotypes are also given labels as in Bugawan et al 15 showing the identity of the À3223 and À1914 alleles, followed in parentheses by the eight SNP haplotype ID used previously. 16 *Nominal P ¼ 0.009.
